CGT · 림프종

328개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved328 programs
CGTCurated CoreFDANovartisApproved

tisagenlecleucel (Kymriah, tisa-cel)

ALL, DLBCL, FL · CD19

#CD19#CGT#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 48Status Approved
CGTLimited DataGlaxoSmithKlinePhase 1

19 (T2, 19, 19(T2)28z1xx TRAC T cell)

B-Cell Lymphoma; Large B-cell Lymphoma · B-Cell Lymphoma

#B-CellLymphoma#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 340Status Recruiting
CGTLimited DatastaleTakedaPhase 1

19 (T2, 19, 19(T2)28z1xx CAR T cells)

Diffuse Large B Cell Lymphoma; Primary Mediastinal Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 182Status Recruiting
CGTStandard DatabasestaleAstraZenecaPhase 2

autologous CD19-directed chimeric antigen receptor (CAR, autologous CD19-directed chimeric antigen receptor, autologous CD19-directed chimeric antigen receptor (CAR) T-cells)

Relapsed Non Hodgkin Lymphoma; Relapsed Adult ALL · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 154Status Recruiting
CGTStandard DatabasestaleAmgenPhase 3

Asparaginase Erwinia chrysanthemi (Asparaginase Erwinia chrysanthemi, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, recombinant)

Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase3#Popular#cell-gene-therapy+5
Trials 134Status Recruiting
CGTStandard DatabasestaleBioceltech Therapeutics, Ltd.Phase 2

CD19 CAR T cells (CD19 CAR T cells)

Lymphomas Non-Hodgkin's B-Cell; Relapse · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 128Status Recruiting
CGTLimited DatastaleJuventas Cell Therapy Ltd.Phase 1

CD19 CAR-T (CD19 CAR-T)

B-cell Malignancy; B-cell Lymphoma · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 93Status Active
CGTLimited DatastaleFondazione Policlinico Universi…Preclinical

Chimeric Antigen Receptor (Chimeric Antigen Receptor)

Lymphoma · Lymphoma

#Lymphoma#CGT#Preclinical#Popular#cell-gene-therapy+4
Trials 91Status Recruiting
CGTStandard DatabasestaleHoffmann-La RochePhase 2

Interferon-Alfa-2b (Interferon-Alfa-2b)

Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface; Malignant Peritoneal Mesothelioma · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 88Status Active
CGTStandard DatabasestaleShanghai Ming Ju Biotechnology …Phase 2

CD19-targeted Chimeric Antigen Receptor (CAR, CD19-targeted Chimeric Antigen Receptor, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)

Lymphoma, Non-Hodgkin; Diffuse Large B Cell Lymphoma · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 64Status Active
CGTLimited DatastaleMerck Sharp & Dohme LLCPhase 1

Stem cell infusion (Stem cell infusion)

Leukemia; Lymphoma · Leukemia

#Leukemia#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 62Status Active
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

chimeric antigen receptor T cell treatment (chimeric antigen receptor T cell treatment)

T Cell Lymphoma; T-cell Leukemia · FRα

#FR#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 62Status Active
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CAR-T cells (Autologous CAR-T cells)

Leukemia; Lymphoma · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Active
CGTStandard DatabasestaleSanofiPhase 2

gemcitabin (gemcitabin)

Extranodal NK/T-cell Lymphoma, Nasal Type · Extranodal NK/T-cell Lymphoma, Nasal Typ

#ExtranodalNKT-cellLymphomaNasalT#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Active
CGTLimited DatastaleSinobioway Cell Therapy Co., Lt…Preclinical

CD19-targeted CAR-T cells (CD19-targeted CAR-T cells)

Lymphoma · CD19

#CD19#CGT#Preclinical#Popular#cell-gene-therapy+5
Trials 60Status Active
CGTStandard DatabasestaleBellicum PharmaceuticalsPhase 2

Chimeric antigen receptor (CAR, Chimeric antigen receptor, Chimeric antigen receptor (CAR) T-cell therapy)

Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 60Status Discontinued
CGTStandard DatabasestaleAbbottPhase 2

Zidovudine (Zidovudine)

Lymphoproliferative Disorder; HHV-8 · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
CGTLimited DatastaleHan weidongPhase 2

cytokine-induced killer cell (cytokine-induced killer cell)

Solid Tumors; B Cell Lymphoma · Solid Tumors

#SolidTumors#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 60Status Active
CGTStandard DatabasestaleAbClonPhase 2

Anti-CD19 Chimeric Antigen Receptor T cell (AT101, AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 59Status Recruiting
CGTStandard DatabasestaleArtiva Biotherapeutics, Inc.Phase 2

Allogeneic NK cells (Allogeneic NK cells)

Refractory Rheumatoid Arthritis (RA); Idiopathic Inflammatory Myopathies (IIMs) · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Recruiting

1 / 17 pages

← PreviousNext →